{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T13:28:17Z","timestamp":1692710897147},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AWHONN Lifelines"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1111\/j.1552-6356.2006.00046.x","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T18:11:40Z","timestamp":1280254300000},"page":"250-254","source":"Crossref","is-referenced-by-count":4,"title":["The Contraceptive Patch: Latest Developments"],"prefix":"10.1016","volume":"10","author":[{"given":"Kathleen","family":"Courtney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2 Suppl.2","key":"10.1111\/j.1552-6356.2006.00046.x_bb0010","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0015-0282(01)03261-7","article-title":"Pharmacokinetic overview of Ortho Evra\/Evra","volume":"77","author":"Abrams","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"2 Suppl.2","key":"10.1111\/j.1552-6356.2006.00046.x_bb0015","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0015-0282(01)03263-0","article-title":"Assessment of compliance with a weekly contraceptive patch (Ortho Evra\/Evra) among North American women","volume":"77","author":"Archer","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1111\/j.1552-6356.2006.00046.x_bb0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/1091592305279122","article-title":"Body weight and contraceptives: Exploring the relationship and dosage risks","volume":"9","author":"Brucker","year":"2005","journal-title":"AWHONN Lifelines"},{"key":"10.1111\/j.1552-6356.2006.00046.x_bb0025","article-title":"Drug\u2010patch safety triggers an FDA probe","author":"Fallik","year":"2006","journal-title":"Philadelphia Inquirer"},{"key":"10.1111\/j.1552-6356.2006.00046.x_bb0030","unstructured":"Food and Drug Administration.(2005).FDA updates labeling for Ortho Evra patch.Retrieved March 3, 2006, from www.fda.gov\/bbs\/topics\/news\/2005\/NEW01262.html"},{"issue":"6","key":"10.1111\/j.1552-6356.2006.00046.x_bb0035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1745-7599.2004.tb00444.x","article-title":"Nondaily hormonal contraception: Considerations in contraceptive choice and patient counseling","volume":"16","author":"Freeman","year":"2004","journal-title":"Journal of the American Academy of Nurse Practitioners"},{"issue":"2","key":"10.1111\/j.1552-6356.2006.00046.x_bb0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.contraception.2005.08.002","article-title":"Medical eligibility criteria for new contraceptive methods: Combined hormonal patch, combined hormonal vaginal ring and the etonogestrel implant","volume":"73","author":"Gaffield","year":"2006","journal-title":"Contraception"},{"issue":"7","key":"10.1111\/j.1552-6356.2006.00046.x_bb0045","first-page":"7","article-title":"Assessing rare event reports: A numerator in search of a denominator","volume":"8","author":"Grimes","year":"2004","journal-title":"Dialogues in Contraception"},{"issue":"1","key":"10.1111\/j.1552-6356.2006.00046.x_bb0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2307\/2991522","article-title":"Unintended pregnancy in the United States","volume":"30","author":"Henshaw","year":"1998","journal-title":"Family Planning Perspectives"},{"issue":"2","key":"10.1111\/j.1552-6356.2006.00046.x_bb0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.contraception.2005.08.011","article-title":"Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"key":"10.1111\/j.1552-6356.2006.00046.x_bb0060","series-title":"Ortho Evra full U.S.prescribing information","author":"Ortho\u2010McNeil Pharmaceutical, Inc","year":"2005"},{"key":"10.1111\/j.1552-6356.2006.00046.x_bb0065","series-title":"Results of two epidemiological studies provide important new clinical information about the safety of Ortho Evra","author":"Ortho Women\u2019s Health and Urology Division, Ortho\u2010McNeil Pharmaceutical, Inc","year":"2006"},{"issue":"4","key":"10.1111\/j.1552-6356.2006.00046.x_bb0070","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2307\/2136191","article-title":"Measuring compliance among oral contraceptive users","volume":"28","author":"Potter","year":"1996","journal-title":"Family Planning Perspectives"},{"issue":"2","key":"10.1111\/j.1552-6356.2006.00046.x_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2307\/2991665","article-title":"Compliance, counseling and satisfaction with oral contraceptives: A prospective evaluation","volume":"30","author":"Rosenberg","year":"1998","journal-title":"Family Planning Perspectives"},{"key":"10.1111\/j.1552-6356.2006.00046.x_bb0080","series-title":"Remington: The science and practice of pharmacy","article-title":"Hormone and hormone antagonists","author":"Ruchalski","year":"2005"},{"issue":"2 Suppl.2","key":"10.1111\/j.1552-6356.2006.00046.x_bb0085","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0015-0282(01)03264-2","article-title":"A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra\/Evra)","volume":"77","author":"Sibai","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1111\/j.1552-6356.2006.00046.x_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2004.02.010","article-title":"Venous thromboembolic disease in users of low\u2010estrogen combined estrogen\u2010progestin oral contraceptives","volume":"70","author":"Sidney","year":"2004","journal-title":"Contraception"},{"key":"10.1111\/j.1552-6356.2006.00046.x_bb0095","series-title":"A clinical guide for contraception","author":"Speroff","year":"2005"},{"issue":"1","key":"10.1111\/j.1552-6356.2006.00046.x_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3949\/ccjm.73.1.45","article-title":"How should we advise patients about the contraceptive patch, given the FDA warning?","volume":"73","author":"Thacker","year":"2006","journal-title":"Cleveland Clinic Journal of Medicine"},{"issue":"2","key":"10.1111\/j.1552-6356.2006.00046.x_bb0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.contraception.2004.03.009","article-title":"Contraceptive failure in the United States","volume":"70","author":"Trussell","year":"2004","journal-title":"Contraception"},{"issue":"3","key":"10.1111\/j.1552-6356.2006.00046.x_bb0110","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: The vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"Van Den Heuvel","year":"2005","journal-title":"Contraception"},{"issue":"2","key":"10.1111\/j.1552-6356.2006.00046.x_bb0115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.maturitas.2004.03.016","article-title":"Levonorgestrel and 17beta\u2010estradiol given transdermally for the prevention of postmenopausal osteoporosis","volume":"50","author":"Warming","year":"2005","journal-title":"Maturitas"},{"key":"10.1111\/j.1552-6356.2006.00046.x_bb0120","series-title":"Cardiovascular disease and steroid hormone contraception: Report of a WHO scientific group","author":"World Health Organization","year":"1998"},{"key":"10.1111\/j.1552-6356.2006.00046.x_bb0125","series-title":"Medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2004"}],"container-title":["AWHONN Lifelines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091592315314783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091592315314783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,9]],"date-time":"2018-12-09T04:54:26Z","timestamp":1544331266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091592315314783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S1091592315314783"],"URL":"https:\/\/doi.org\/10.1111\/j.1552-6356.2006.00046.x","relation":{},"ISSN":["1091-5923"],"issn-type":[{"value":"1091-5923","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}